Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test - PubMed (original) (raw)
Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test
Yoshihisa Kitamura et al. Pharmacol Biochem Behav. 2002 Jan-Feb.
Abstract
We examined the effects of adrenocorticotropic hormone (ACTH) on the immobilization of rats in the forced swim test with the administration of imipramine, desipramine, or lithium. A single administration of either imipramine (10-30 mg/kg, i.p.) or desipramine (30 mg/kg, i.p.) significantly decreased the duration of immobility in normal rats in a dose-dependent manner. Lithium (10-100 mg/kg, p.o.), however, had no affect on the performance of rats in the forced swim test. ACTH (100 microg/day), administered subcutaneously to rats for 1, 3, 7, and 14 days, had no apparent effect on the duration of immobility in this test. The immobility-decreasing effect induced by a single administration of either imipramine (10-30 mg/kg, i.p.) or desipramine (30 mg/kg, i.p.) was blocked by chronic administration of ACTH for 3-14 days. The reduction of immobility, induced by chronic administration of imipramine (10 mg/kg, i.p.) for 15 days, was blocked by treatment with ACTH for 14 days. When lithium (100 mg/kg, p.o.) was administered for 15 days concurrently with imipramine (10 mg/kg, i.p.), we observed a significant decrease in immobility in rats treated with ACTH for 14 days. We suggest that chronic treatment of rats with ACTH may prove to be an effective model of tricyclic antidepressants-treatment-resistant depression.
Similar articles
- Effect of ACTH on the imipramine- and desipramine-induced decrease in duration of immobility time as measured in a rat forced swimming test.
Takamori K, Yoshida S, Okuyama S. Takamori K, et al. Life Sci. 2001 Sep 7;69(16):1891-6. doi: 10.1016/s0024-3205(01)01262-0. Life Sci. 2001. PMID: 11693269 - Influence of imipramine on the duration of immobility in chronic forced-swim-stressed rats.
Kitamura Y, Araki H, Nagatani T, Takao K, Shibata K, Gomita Y. Kitamura Y, et al. Acta Med Okayama. 2004 Dec;58(6):271-4. doi: 10.18926/AMO/32092. Acta Med Okayama. 2004. PMID: 15762295 - Effects of imipramine and bupropion on the duration of immobility of ACTH-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA.
Kitamura Y, Fujitani Y, Kitagawa K, Miyazaki T, Sagara H, Kawasaki H, Shibata K, Sendo T, Gomita Y. Kitamura Y, et al. Biol Pharm Bull. 2008 Feb;31(2):246-9. doi: 10.1248/bpb.31.246. Biol Pharm Bull. 2008. PMID: 18239281 - [Interaction of 5-HT and HPA axis in depression and treatment-resistant depression].
Kitamura Y, Araki H, Gomita Y. Kitamura Y, et al. Nihon Yakurigaku Zasshi. 2002 Jun;119(6):319-25. doi: 10.1254/fpj.119.319. Nihon Yakurigaku Zasshi. 2002. PMID: 12089903 Review. Japanese. - Ethopharmacology of imipramine in the forced-swimming test: gender differences.
Barros HM, Ferigolo M. Barros HM, et al. Neurosci Biobehav Rev. 1998;23(2):279-86. doi: 10.1016/s0149-7634(98)00029-3. Neurosci Biobehav Rev. 1998. PMID: 9884121 Review.
Cited by
- Effects of pramipexole on the duration of immobility during the forced swim test in normal and ACTH-treated rats.
Kitagawa K, Kitamura Y, Miyazaki T, Miyaoka J, Kawasaki H, Asanuma M, Sendo T, Gomita Y. Kitagawa K, et al. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jul;380(1):59-66. doi: 10.1007/s00210-009-0405-0. Epub 2009 Mar 10. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 19274453 - Mood Regulatory Actions of Active and Sham Nucleus Accumbens Deep Brain Stimulation in Antidepressant Resistant Rats.
Kale RP, Nguyen TTL, Price JB, Yates NJ, Walder K, Berk M, Sillitoe RV, Kouzani AZ, Tye SJ. Kale RP, et al. Front Hum Neurosci. 2021 Jul 19;15:644921. doi: 10.3389/fnhum.2021.644921. eCollection 2021. Front Hum Neurosci. 2021. PMID: 34349629 Free PMC article. - Metabolomic signatures and microbial community profiling of depressive rat model induced by adrenocorticotrophic hormone.
Song J, Ma W, Gu X, Zhao L, Jiang J, Xu Y, Zhang L, Zhou M, Yang L. Song J, et al. J Transl Med. 2019 Jul 15;17(1):224. doi: 10.1186/s12967-019-1970-8. J Transl Med. 2019. PMID: 31307473 Free PMC article. - Novel drug developmental strategies for treatment-resistant depression.
Borbély É, Simon M, Fuchs E, Wiborg O, Czéh B, Helyes Z. Borbély É, et al. Br J Pharmacol. 2022 Mar;179(6):1146-1186. doi: 10.1111/bph.15753. Epub 2022 Jan 26. Br J Pharmacol. 2022. PMID: 34822719 Free PMC article. Review. - Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance.
Walker AJ, Price JB, Borreggine K, Sutor SL, Gogos A, McGillivray JA, Frye MA, Tye SJ. Walker AJ, et al. Transl Psychiatry. 2019 Mar 15;9(1):113. doi: 10.1038/s41398-019-0434-5. Transl Psychiatry. 2019. PMID: 30877268 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources